On Tuesday Walmart announced it would begin to help drug companies and research firms identify and recruit individuals to fill their clinical trials, reported Reuters.
Walmart Healthcare Research Institute will now find participants for clinical trials, and Walmart also hosts MyHealthJourney, a patient portal that helps people find upcoming research trials and track their care.
Walmart’s expansion into clinical trial recruitment could bring it new streams of revenue from drug companies.
John Wigneswaran, Walmart’s chief medical officer, said the retailer’s clinics and pharmacies will become a “funnel” for healthcare organizations that want access to its diverse populations of customers for possible trials and studies.
Patient-recruitment is difficult in clinical trials. Studies can be delayed or terminated when organizations are not able to get enough people to participate or when patients drop out of the trial.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Urged to Enforce Rarely Used Antitrust Law Against Retail Giants
Mar 28, 2024 by
CPI
UK’s Fingleton Bolsters Team with New Additions
Mar 28, 2024 by
CPI
Britain’s Competition Regulator Clears Aviva’s Acquisition of AIG Life UK
Mar 28, 2024 by
CPI
White House Implements New AI Safeguards to Protect Rights and Safety
Mar 28, 2024 by
CPI
Denver Court Sets August Date for Kroger-Albertsons Merger Showdown
Mar 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI